...
首页> 外文期刊>European Journal of Medicinal Chemistry: Chimie Therapeutique >Synthesis, vasorelaxant activity, and molecular modeling study of some new phthalazine derivatives
【24h】

Synthesis, vasorelaxant activity, and molecular modeling study of some new phthalazine derivatives

机译:某些新型酞嗪衍生物的合成,血管舒张活性和分子模型研究

获取原文
获取原文并翻译 | 示例

摘要

New phthalazine-based vasodilators were synthesized through the chloroacylation of the starting compound 1-hydrazinophthalazine 4 to give the two key intermediates 5 and 7. These intermediates were used to alkylate various cyclic amines to furnish the final compounds 6a-h and 8a-h. Compounds were tested for their vasorelaxant activities against nor-adrenaline-induced spasm on thoracic rat aorta rings and compared to the reference drug, prazosin. Seven compounds showed higher activity than prazosin, especially compound 8d having an IC 50 = 0.10 mM. Molecular modeling studies, including fitting of the synthesized compounds to a 3D-pharmacophore and their docking into optimized homology model as α 1-AR antagonists showed high docking score and fit values. Most vasodilation activities of tested compounds are consistent with their molecular modeling results.
机译:通过原料化合物1-肼基酞嗪4的氯酰化反应合成了新的基于酞嗪的血管扩张剂,得到了两个关键的中间体5和7。这些中间体用于烷基化各种环胺,从而提供最终化合物6a-h和8a-h。测试化合物对去甲肾上腺素诱导的胸主动脉环痉挛的血管舒张活性,并与参考药物哌唑嗪进行比较。七个化合物显示出比哌唑嗪更高的活性,特别是具有IC 50 = 0.10 mM的化合物8d。分子建模研究(包括将合成的化合物拟合至3D药效团并将其对接至优化的同源性模型中作为α1-AR拮抗剂)显示出较高的对接得分和拟合值。被测化合物的大多数血管舒张活性与其分子模拟结果一致。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号